Farmaceutica, i generici di Teva lanciano una maxi offerta da 40,1 miliardi per Mylan - la Repubblica
イスラエルのTeva Pharmaceuticals、同業のMylanに買収提案 - 化学業界の話題
How a Teva-Mylan deal will affect Indian pharma companies | Mint
Teva Accuses Mylan of 'Desperate Attempt' to Suppress Bid - Drug Discovery and Development
Teva offers to buy Mylan in $40 billion deal | The Times of Israel
FDA Approves Teva's Generic EpiPen As Stock Rises
Teva plans competitor for Mylan's EpiPen - Drug Delivery Business
Valsartan recall expands to Mylan, Teva products | Fierce Pharma
Teva drops bid for Mylan, buys Allergan's generics unit | Pittsburgh Post-Gazette
Teva makes $40.1 billion takeover bid for Mylan | Mint
Drugmaker Teva makes $40B bid for rival Mylan
Mylan share price plunges after Teva abandons bid | Financial Times
Teva loses Copaxone patent dispute case to Mylan in UK - Pharmaceutical Business review
Mylan makes hostile $31.2 billion Perrigo bid to thwart Teva | Mint
Generici, da Teva Opa su Mylan - Pharmaretail
US lawmakers push Mylan, Teva over drug pricing probe - www.israelhayom.com
Teva offers to buy Mylan in $40 billion deal | The Times of Israel
$40B deal: Teva offers to buy Mylan
How Mylan tried to keep Teva from selling a generic EpiPen
Teva Pharmaceutical Industries' quest to acquire Mylan NV could wind up in a Dutch court - Pittsburgh Business Times
Farmaceutico: Teva ci riprova con Mylan, verso rialzo offerta fino almeno a 43 mld $
Teva Makes Hostile Bid To Acquire Mylan
With Teva Bid Off the Table, Mylan's Stock In 'Show-Me' Mode - WSJ
Mylan: no all'offerta di Teva. A meno che non riveda il prezzo... - FarmaciaVirtuale.it
Mylan regina dei titoli farmaceutici a Wall Street. Crollano Teva e Momenta - Economia e Finanza - Repubblica.it
